Logo image of GRVY

GRAVITY CO LTD-SPONSORED ADR (GRVY) Stock Fundamental Analysis

NASDAQ:GRVY - Nasdaq - US38911N2062 - ADR - Currency: USD

66.16  -0.11 (-0.17%)

Fundamental Rating

6

GRVY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 74 industry peers in the Entertainment industry. GRVY has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. GRVY has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

GRVY had positive earnings in the past year.
In the past 5 years GRVY has always been profitable.
In the past 5 years GRVY always reported a positive cash flow from operatings.
GRVY Yearly Net Income VS EBIT VS OCF VS FCFGRVY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B

1.2 Ratios

With an excellent Return On Assets value of 11.39%, GRVY belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
GRVY has a Return On Equity of 13.57%. This is amongst the best in the industry. GRVY outperforms 85.14% of its industry peers.
With an excellent Return On Invested Capital value of 10.97%, GRVY belongs to the best of the industry, outperforming 87.84% of the companies in the same industry.
GRVY had an Average Return On Invested Capital over the past 3 years of 21.19%. This is below the industry average of 24.07%.
The last Return On Invested Capital (10.97%) for GRVY is well below the 3 year average (21.19%), which needs to be investigated, but indicates that GRVY had better years and this may not be a problem.
Industry RankSector Rank
ROA 11.39%
ROE 13.57%
ROIC 10.97%
ROA(3y)17.98%
ROA(5y)19.54%
ROE(3y)22.9%
ROE(5y)26.19%
ROIC(3y)21.19%
ROIC(5y)26.48%
GRVY Yearly ROA, ROE, ROICGRVY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

Looking at the Profit Margin, with a value of 15.45%, GRVY belongs to the top of the industry, outperforming 91.89% of the companies in the same industry.
GRVY's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 16.05%, GRVY belongs to the best of the industry, outperforming 87.84% of the companies in the same industry.
GRVY's Operating Margin has improved in the last couple of years.
GRVY has a Gross Margin of 38.15%. This is comparable to the rest of the industry: GRVY outperforms 43.24% of its industry peers.
GRVY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.05%
PM (TTM) 15.45%
GM 38.15%
OM growth 3Y-9.86%
OM growth 5Y4.98%
PM growth 3Y2.1%
PM growth 5Y8.95%
GM growth 3Y-5.47%
GM growth 5Y7.99%
GRVY Yearly Profit, Operating, Gross MarginsGRVY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GRVY is creating value.
The debt/assets ratio for GRVY has been reduced compared to a year ago.
GRVY Yearly Shares OutstandingGRVY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M
GRVY Yearly Total Debt VS Total AssetsGRVY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.2 Solvency

GRVY has an Altman-Z score of 6.57. This indicates that GRVY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of GRVY (6.57) is better than 89.19% of its industry peers.
There is no outstanding debt for GRVY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.57
ROIC/WACC4.73
WACC2.32%
GRVY Yearly LT Debt VS Equity VS FCFGRVY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B 300B 400B 500B

2.3 Liquidity

GRVY has a Current Ratio of 6.50. This indicates that GRVY is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of GRVY (6.50) is better than 94.59% of its industry peers.
GRVY has a Quick Ratio of 6.50. This indicates that GRVY is financially healthy and has no problem in meeting its short term obligations.
GRVY has a better Quick ratio (6.50) than 94.59% of its industry peers.
Industry RankSector Rank
Current Ratio 6.5
Quick Ratio 6.5
GRVY Yearly Current Assets VS Current LiabilitesGRVY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

1

3. Growth

3.1 Past

GRVY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.58%.
GRVY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.49% yearly.
GRVY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.78%.
Measured over the past years, GRVY shows a small growth in Revenue. The Revenue has been growing by 6.77% on average per year.
EPS 1Y (TTM)-34.58%
EPS 3Y9.05%
EPS 5Y16.49%
EPS Q2Q%-17.97%
Revenue 1Y (TTM)-23.78%
Revenue growth 3Y6.56%
Revenue growth 5Y6.77%
Sales Q2Q%-16.3%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GRVY Yearly Revenue VS EstimatesGRVY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

4

4. Valuation

4.1 Price/Earnings Ratio

GRVY is valuated cheaply with a Price/Earnings ratio of 7.97.
Based on the Price/Earnings ratio, GRVY is valued cheaply inside the industry as 93.24% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.87. GRVY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.97
Fwd PE N/A
GRVY Price Earnings VS Forward Price EarningsGRVY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GRVY is valued cheaper than 85.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.15
GRVY Per share dataGRVY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The excellent profitability rating of GRVY may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.48
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GRVY!.
Industry RankSector Rank
Dividend Yield N/A

GRAVITY CO LTD-SPONSORED ADR

NASDAQ:GRVY (8/15/2025, 8:26:02 PM)

66.16

-0.11 (-0.17%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-10 2025-11-10
Inst Owners15.98%
Inst Owner Change-3.17%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap459.74M
Analysts0
Price TargetN/A
Short Float %0.39%
Short Ratio1.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.97
Fwd PE N/A
P/S 1.23
P/FCF N/A
P/OCF N/A
P/B 1.08
P/tB 1.09
EV/EBITDA 7.15
EPS(TTM)8.3
EY12.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS53.72
BVpS61.17
TBVpS60.51
PEG (NY)N/A
PEG (5Y)0.48
Profitability
Industry RankSector Rank
ROA 11.39%
ROE 13.57%
ROCE 13.88%
ROIC 10.97%
ROICexc 10.97%
ROICexgc 11.09%
OM 16.05%
PM (TTM) 15.45%
GM 38.15%
FCFM N/A
ROA(3y)17.98%
ROA(5y)19.54%
ROE(3y)22.9%
ROE(5y)26.19%
ROIC(3y)21.19%
ROIC(5y)26.48%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)26.81%
ROCE(5y)33.51%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-70.66%
OM growth 3Y-9.86%
OM growth 5Y4.98%
PM growth 3Y2.1%
PM growth 5Y8.95%
GM growth 3Y-5.47%
GM growth 5Y7.99%
F-ScoreN/A
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.5
Quick Ratio 6.5
Altman-Z 6.57
F-ScoreN/A
WACC2.32%
ROIC/WACC4.73
Cap/Depr(3y)76.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.86%
Profit Quality(3y)99.21%
Profit Quality(5y)101.85%
High Growth Momentum
Growth
EPS 1Y (TTM)-34.58%
EPS 3Y9.05%
EPS 5Y16.49%
EPS Q2Q%-17.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.78%
Revenue growth 3Y6.56%
Revenue growth 5Y6.77%
Sales Q2Q%-16.3%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-42.16%
EBIT growth 3Y-3.95%
EBIT growth 5Y12.09%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.73%
FCF growth 3Y1.79%
FCF growth 5Y25.16%
OCF growth 1Y-40.68%
OCF growth 3Y1.93%
OCF growth 5Y24.4%